Danielle F. Atibalentja

Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Anti-PD-L1 F(ab) Conjugated PEG-PLGA Nanoparticle Enhances Immune Checkpoint Therapy”.

Anti-PD-L1 F(ab) Conjugated PEG-PLGA Nanoparticle Enhances Immune Checkpoint Therapy

Nanotheranostics(2022)10.7150/ntno.65544

N/A

0DataRank · unranked

51 citations

Danielle F. Atibalentja, Lilian Yao, Jangho Park, Sibu Kuruvilla, Dean W. Felsher +1 more

A big step for MYC-targeted therapies

Trends in cancer(2024)10.1016/j.trecan.2024.03.009

N/A

0DataRank · unranked

3 citations

Anja Deutzmann, Dean W. Felsher, Danielle F. Atibalentja

Targeting the MYC oncogene with a selective bi-steric mTORC1 inhibitor elicits tumor regression in MYC-driven cancers

Cell chemical biology(2025)10.1016/j.chembiol.2025.07.004

N/A

0DataRank · unranked

6 citations

Yu Chi Yang, Ian Lai, Jangho Park, Lilian Yao, James W. Evans +15 more